Logo Logo Logo Logo Logo
  • Latest News
  • Podcasts
  • How to Contribute
  • Network
  • Resources
  • About DHC
  • Meet The Team
  • Contact Us
  • Subscribe for Updates
  • Latest News
  • Podcasts
  • How to Contribute
  • Network
  • Resources
  • About DHC
  • Meet The Team
  • Contact Us
  • Subscribe for Updates

29 May Liraglutide Lowers Cardiovascular Outcomes in Type 2 Diabetes

Posted at 00:00h in Clinical Trials by Andrea Frassoni

New England Journal of Medicine

Diabetes research shows Liraglutide lowers Cardiovascular outcomes in Type 2 Diabetes, per The New England Journal of Medicine.

Tags:
Clinical Trials, Drugs & Therapy, For Doctors
Share
Print page


Topics
  • Awareness
  • Business
  • Clinical Trials
  • Drugs & Therapy
  • Entertainment
  • Fashion
  • For Doctors
  • For Parents
  • For Patients
  • General
  • Gestational
  • Type 1
  • Type 2
  • Pets
  • Podcasts
  • Politics
  • Sports
  • Tech
logo
Phone: 1-888-400-1573
  • Latest News
  • Podcasts
  • How to Contribute
  • Network
  • Resources
  • About DHC
  • Meet The Team
  • Contact Us
  • Subscribe for Updates
  • For Doctors
  • For Parents
  • For Patients
  • Podcasts
  • Video
  • Drugs & Therapy
  • General
© Copyright CMS Connections 1-888-400-1573